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Summary: Conventional methods for the determination of blood glucose are not suitable for application in
vivo. It is therefore necessary to seek other methods for monitoring blood glucose as a controlled variable of
pancreatic hormonal regulation. Physical methods are preferable to conventional chemical methods, because
the chosen methods should not consume or chemically modify glucose. There are two main types of physical
chemical methods, which can be considered for this purpose:
1) invasive methods, in which measurements are made directly in the blood stream, and
2) non-invasive methods.
The first type is represented by electrochemical catalysts and fuel cells, the latter by spectroscopic procedures
(mainly NMR- and IR-spectroscopy).
Introduction
With respect to the dynamic state of body constitu-
ents, the human organism is an open system. In this
context, the physiological and pathobiochemical reg-
ulation of blood glucose and its associated dynamic
equilibria have always been of especial interest.
It is now possible to regulate blood glucose extracor-
porally, using insulin infusion controlled by a glucose
monitoring system (known as the "artificial pan-
creas")· This permits the construction of individually
programmed and computer-controlled regulatory de-
vices. The operational reliability of such systems is
relatively high, but a continuously operating, reliable
and rapid method for determination of the circulating
blood glucose concentration is still lacking. Further
development of regulatory systems will depend on
such a system.
Conventional wet chemical methods (e. g. hexokinase/
glucose-6-phosphate dehydrogenase, glucose dehy-
drogenase or glucose oxidase/peroxidase methods)
(1—5) cannot be used in vivo, because substrate-
consuming methods are not applicable inside the or-
ganism. Extracorporal determination of glucose via a
double lumen catheter with the aid of continual re-
cording can only be a temporary arrangement for a
limited time period. It suffers from the disadvantages
of all invasive methods, i.e. a relatively high con-
sumption of blood and damage to the vein wall with
all its attendant complications (tissue reaction, fibrin
layer formation, deposition of protein, thromboses,
etc.) (6).
This restriction on the application of conventional
methods for the determination of blood glucose
makes it necessary to seek methods, which do not
consume or chemically modify glucose, and which are
sufficiently accurate to act as regulators for the hor-
monal control of blood glucose via the artificial pan-
creas. Conventional chemical methods must therefore
be replaced by physical chemical methods.
There are two different physical principles of meas-
urement:
1) invasive methods, in which measurements are
made directly in the tissue or blood, and
2) non-invasive methods.
The first type is represented mainly by electrochemical
catalysts, the latter by spectroscopic methods. Other
procedures (e. g. polarimetry, optical rotation, meas-
urement of the change of potential at cell membranes
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(condimetry), measurement of transcutaneous resist-
ance, light scattering, etc.) have all been tested and
found to be either too unspecific or too insensitive.
They have occasionally been applied in daily clinical
practice, but a satisfactory correlation of response
and blood glucose concentration has not been shown
for any of the named procedures.
1. Invasive Procedures
Electrochemical catalysts, also known as biosensors,
have already been used for the development of im-
plantable glucose sensors. The detector system may
or may not contain an immobilized enzyme.
1.1 Biosensors containing enzymes
Principle
The best known of these procedures uses a polaro-
graphic sensor to measure the oxygen uptake during
the oxidation of glucose in the presence of glucose
oxidase. Measurement is performed with a platinum
cathode (coated with glucose oxidase containing po-
lyacrylamide) and a Ag/AgCl anode in the electrolyte
solution (7-8).
The hydrogen peroxide electrode operates on a similar
principle to that of the oxygen electrode. Oxidation
of glucose in the presence of glucose oxidase produces
gluconolactone and hydrogen peroxide. The latter is
measured directly by an electrode (platinum anode,
silver cathode; similar to the well known Clark elec-
trode) after passing through selective membranes of
various porosities, and the response is proportional
to the glucose concentration.
Evaluation
The oxygen electrode enables a sufficiently exact,
rapid and interference-free measurement of oxygen
uptake, which is proportional to the glucose concen-
tration. The method has been used in a continuous
extracorporal analytical device (Biostator) (9 — 10).
On-line coupling of an oxygen electrode with a cal-
culator and an insulin infusion pump represents an
"artificial endocrine pancreas" (also called an "arti-
ficial ß-cell").
The hydrogen peroxide electrode can be used for the
extracorporal measurement of glucose in fluids, es-
pecially whole blood. This method has the advantage
of low susceptibility to interference, since electrode-
active substances (e. g. ascorbic acid, glutathione, uric
acid, cysteine) are excluded by the various membranes
(11).
1.2 Fuel cells (enzyme-free biosensors)
Principle
The principle of this method was first described by
Bessman & Schultz (12). Glucose is oxidized anodi-
cally to gluconic acid with the aid of a noble metal
electrode (platinum or gold), and Oxygen reduction
at the cathode is measured directly, the resulting dif-
fusion current being proportional to the glucose con-
centration. The catalyst is regenerated by the appli-
cation of continuous square wave pulses (30 V, 20 ms,
5s-1) (13).
Evaluation
At present the noble metal electrode suffers from a
lack of specificity. Other oxidizable substances, like
amino acids and proteins, as well as urea and creati-
nine, give rise to an interfering anodic partial current
density, for which there is no known remedy. These
substances generate an electrode potential similar to
that for glucose, and in the same potential range, so
that the signals are superimposed.
Interpretation of these electrode currents in the voU
tagram is very difficult, and in principle it is not fully
understood. Whether the electrochemical determina-
tion of glucose represents the registration of a cata-
lytic process, or whether the reduction or oxidation
of glucose is itself directly responsible for the electrode
current, is an open question. In polarograms with a
mercury dropping electrode^ which permit quantita-
tive measurement of oxidation and reduction pro-
cesses by characteristic alterations of the current (po-
larographic steps), we detected no such changes, even
at very high glucose concentrations. We must there-
fore conclude that the glucose-dependent increase of
the electrode current as shown by Soeldner et al. (14—
19) cannot be explained by a simple redox reaction
of glucose at the electrodes.
For the reasons stated, the functional efficiency of
these electrodes is very limited when they are im-
planted in tissues, but they may be a little more
suitable for use in blood (29—23).
Section summary
Both of the above-mentioned invasive methods, the
enzyine-based biosensors and the fuel cell, have been
used in vivo with hitherto only very limited, short-
term success (24—31). For extracorporal measure-
ments, however, they have been applied to a variety
of scientific and clinical problems* with notable results
(11, 32-44).
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1.3 Other biosensors
In principle, any physical chemical method can be
incorporated into a biosensors» provided it does not
cause irreversible organ damage. Nevertheless, with
respect to glucose measurement in vivo, the number
of possible methods is minimal (45).
Principle
Piezoelectric crystals employ the electrically generated
oscillations of quartz crystals, whose frequency is
proportional to the mass of the crystal. Masses of
10"~12 g can be determined in this way. The technique
has been successfully applied to immunoassays.
Optical sensors (optodes) operate on a fluorimetric
principle, using immobilized dehydrogenases. With
the aid of multi-fibre optical conductors (fibre optics),
they can be operated at some distance from the site
of the measurement. They have been introduced suc-
cessfully for both immunological and enzymological
measurements.
FET biosensors (.Reid Effect Transistors) are signal
transducers based on semiconductors. They are de-
signed to respond to alterations in an established
electrostatic field caused by the presence of molecules.
Hitherto, this method has been applied only to pure,
aqueous solutions, or to defined fluids, and not to
body fluids. FET biosensors have proved to be highly
efficient for the determination of the isoelectric points
of antibodies, and are therefore employed as immune
sensors.
Thermistors measure the temperature of exothermic
reactions. With the aid of a flow-through microcalo-
rimeter, they are able to detect very small temperature
shifts during biological reactions, such as the enzymic
conversion of a substrate.
Evaluation
Biosensors, which do not depend on the selective
micro-electronic measurement of molecules (electro^
chemical voltammetry), as described in sections 1.2
and 1.3, unfortunately have no or very limited appli-
cation in vivo. Piezo-crystals promise to become an
interesting detection system for the determination of
enzymes and antibodies, but they appear to be un-
suitable for the determination of glucose. The use of
optical sensors for the determination of glucose in
vivo is not yet possible. A specific effect of glucose
on the conductivity of transistors has not yet been
demonstrated, so that this type of in vivo method is
out of the question. Thermistors show outstanding
sensitivity in the measurement of glucose (down to
0.002 mmol/1), but this applies only to aqueous so-
lutions; the use of thermistors for the in vivo meas-
urement of glucose is inconceivable.
Section summary
On the basis of our present knowledge and the state
of technical development, the application of any other
electronic analytical principle as a biosensor for the
invasive determination of blood glucose in vivo seems
to be out of the question. On the one hand, it may
be worthwhile devoting time to the construction of
membrane-covered cathodes with the highest possible
specific permeability and stable sensitivity. On the
other hand, this positive aspect is offset by the aggra-
vating susceptibility to interference of catalytic bio-
sensors. Furthermore, in order to avoid the problem
of indirect determination by measurement of the re-
action product, it is necessary to seek possible meth-
ods of measuring glucose concentration without con-
sumption or modification of the molecule.
2. Non-invasive Methods
Since there is little prospect for the successful appli-
cation of invasive methods, it is necessary to consider
non-invasive, spectroscopic methods for monitoring
blood glucose in vivo. The practical application of
the methods in question is, however, far from reali-
zation, and the necessary technology crosses many
disciplinary boundaries. Only spectroscopic methods
appear to be suitable for the purpose. These are widely
used routine methods of physics and analytical chem-
istry, which have not yet been fully exploited in med-
icine. Moreover, their specialized application in vivo
is dependent on the solution of many hitherto un-
solved problems. In this respect, only a few of the
various spectroscopic methods appear to be suitable
for coping with the problems of non-invasive moni-
toring in vivo. For example, X-ray spectroscopy is
excluded, since it would cause cellular damage and
gene mutation.
2.1 Nuclear magnetic resonance (NMR)
Principle
Nuclear magnetic resonance (NMR) is one of the
more promising non-invasive methods. It depends on
the fact that most atomic nucleic have a characteristic
spin, and therefore possess a magnetic moment (46).
In an homogeneous, static magnetic field, the vector
of the spin is quantized, so that each orientation of
spin relative to the magnetic field corresponds to a
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discrete energy level. Occupation of these energy levels
shows a Boltzmann distribution, and magnetic reso-
nance absorptions correspond to transitions between
the energy levels, i. e. irradiation energy is absorbed
in quanta, which represent the differences between
energy levels. The area under an absorption curve is
a measure of the intensity of the transition, and this
in turn is proportional to the number of absorbing
nuclei. The NMR spectrum of a finger in a magnetic
field would therefore contain spectroscopic informa-
tion about glucose.
Evaluation
Techniques of signal filtering and subtraction have
raised NMR from a Utopian idea to the status of a
practical technique capable of providing quantitative
information on substrate concentrations in vitro and
in vivo. The requirement for a rather large magnet
and a radiofrequency transmission and receiving sys-
tem means, however, that the method is still very
costly and large-scale. The advantage, however, is that
the excitation and response of the investigated atomic
nuclei occur in the form of low frequency electro-
magnetic radiation. This means that the circulating
concentration of glucose, as well as those of a large
number of other clinical chemical parameters in blood
(47), can be measured rapidly, with avoidance of
bodily contact, and without having to consider opti-
cal, mechanical or electrical interference (48). Since
no reagents are used, economic considerations will
lead to the elevation of this type of analysis to an
important position in future laboratory medicine, and
it can be expected to change the face of conventional
clinical chemical analysis.
Although NMR has been used satisfactorily for the
determination of ATP in vivo in various organs (49),
there is a considerable obstacle to its use for the
determination of glucose in vivo; the relevant carbon
nucleus for the determination of glucose possesses a
relatively low signal intensity compared with the nat-
ural nuclides Ή, 15N, 31P and 13C. In this respect, it
would be much easier to determine the metabolically
active glucose 6-phosphate.
2.2 Electron spin resonance (ESR)
Principle
Electron spin resonance might conceivably be applied
in the same way as NMR spectroscopy for the deter-
mination of glucose in vivo. In a magnetic field the
parameters of electron spin behave analogously to
those of nuclear spin.
Evaluation
In research, ESR is being increasingly used for the
observation of intracellular metabolic processes and
membrane behaviour (50 — 56). No detailed studies
have been reported, however, on the use of ESR for
the determination of glucose. ,
 r
2.3 Positron emission tomography (PET)
Principle
In the PET method, radioactive nuclides are injected,
which emit positrons (positively charged anti-elec-
trons) when they decay. The positrons interact with
the electrons of neighbouring molecules to produce
two mono-energetic gamma rays, which are emitted
in opposite directions, and can therefore be measured
with two separate detectors (57). Thus measurements
are based on a spatial relationship.
Evaluation
At present, this non^-invasive method for monitoring
metabolic processor after incorporation of radioactive
materials (nC, 13N, etc.) is still at the forefront of
research (58). In a few years time, however, this type
of functional diagnosis on the molecular level could
revolutionize laboratory diagnosis. It does not depend
on the random determination of individual parame-
ters in a static situation, but rather provides infor-
mation on biodynamic processes, permitting the inter-
pretation of specific metabolic events (59).
In addition to locating the sites of active metabolism,
this method also enables the surveillance of e. g. blood
flow and perfusion measurements, and can thus pro-
vide an important biochemical basis for the diagnosis
of molecular function. The method therefore achieves
more than the measurement of blood glucose; it meas-
ures glucose turnover in the tissues, thereby directly
providing information on this biologically and clini-
cally relevant process.
2.4 Infrared spectroscopy (IR)
Currently, the most promising method for the non-
invasive determination of blood glucose is infrared
spectroscopy (IR).
Principle
Molecules with a permanent dipole moment or mol-
ecules with a variable dipole absorb energy of the
electromagnetic spectrum in or near to the infrared.
The resulting absorption bands can be assigned to
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specific structural elements. Infrared spectroscopy
measures the electromagnetic radiation energy (wave
number 4000 — 600 cm"1) absorbed by the oscillation
and rotation of functional groups. Absorption of ra-
diation by any molecule occurs only at certain discrete
energy levels, which are characteristic of that mole-
cule. These energies vary, depending on the arrange-
ment of atoms in the molecule. IR spectroscopy is
therefore a relatively simple, rapid and reliable tech-
nique for the chemical identification of molecules or
their structural groups (60 — 63).
Thanks to rapid developments in the field of small,
high performance computers, the quantitative evalu-
ation of the discrete bands of the infrared spectrum
presents no problem. Programs are available (e.g.
least-squares-curve-fitting with Quant-3), which han-
dle the mathematically demanding analysis of multi-
component systems with overlapping bands.
For the application of this technique to glucose mon-
itoring in vivo, it must be possible to use the recorded
spectrum directly. This requires processing of the sig-
nal so that the spectrum is directly related to concen-
tration, involving the addition of spectra (spectral
accumulation for the improvement of signal to noise
ratio), and the intensification of spectra in binary
steps. Understandably, this is only possible with ex-
pensive equipment. Modern FTIR (Fourier Trans-
form 7nfra/?ed spectroscopy) apparatuses, employing
Fourier transformation and a Multiplex facility,
achieve a considerable energy gain, which can be
exploited to decrease the time for registration of the
spectrum, or to improve the signal to noise ratio (64).
Complete computer back-up (e.g. multicomponent
analysis by curve fitting, using the method of least
squares) provides the following extra facilities and
advantages:
a. Generation and further application of pure spectra,
i. e. the spectrum of the dissolved species is produced
by subtraction of the spectrum of the matrix.
b. Practically any desired substance concentration
can be simulated by linear multiplication.
c. A spectral library can therefore be generated, then
used to obtain a summated spectrum by multiple
addition, which agrees as closely as possible with the
sample spectrum. Furthermore, the composition of
the sample can be determined by multiple subtraction
of individual spectra from the sample spectrum.
d. Summation of many spectra to improve the signal
to noise ratio offers a facility for measuring very low
glucose concentrations in hypoglycaemia with suffi-
cient accuracy.
e. By linear combination of individual spectra, it
should also be possible to simultaneously determine
several other parameters in the sample.
Evaluation
The greatest source of interference in this method,
which must first be overcome by modern analytical
techniques, is the high background absorption due to
water. With available light sources, it is not yet pos-
sible to obtain satisfactory results in the so-called
water windows of the near infrared region at 1500 —
1850 and 2000—2500 nm. Since suitable laser diodes
with good monochromatic output are also not yet
available for these ranges, methods must be employed
which record in the middle infrared region, with cor-
rection for interference.
A simple example of the results from a dispersive and
relatively insensitive apparatus is given in figure 1.
Wave number range
Fig. 1. IR-spectrum of human plasma without taking into ac-
count the subcutis and its constituent glycoproteins.
A (top), original spectra. Left: aqueous protein solution
(81 g/1 bovine serum albumin). Centre: heparin plasma
(patient sample containing about 220 mg/dl glucose).
Right: aqueous glucose solution 1000 mg/dl). Wave-
number range 850 to 1600 cm"1, corresponding to
11 750 to 6250 nm (barium fluoride window; sample
layer about 26 nm; transmission scale: upper edge of
frame 100%, lower edge about 18% transmission).
B (centre); spectra of the same dissolved substances after
subtraction of the spectrum of the aqueous medium. It
can be seen that the main components of plasma are
proteins (right half of the difference spectrum).
C (bottom), difference spectrum of heparin plasma after
subtraction of the spectrum of the aqueous protein (part
A). The absorption bands of glucose can be seen, al-
though they are partly covered. For easier identification,
the bands of the glucose spectrum from part B have
been superimposed as a dotted line.
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The treatment of results shown in figure 1 is only
suitable for the qualitative identification of the ab-
sorption bands, because each spectral subtraction
leads to considerable deterioration of the signal to
noise ratio. Multicomponent analysis without spectral
subtraction is much more suitable for quantitative
evaluation. The efficient presentation of difference
spectra is only possible by electronic means.
Some exemplary reasons for the difficulties in the IR-
spectroscopic determination of glucose in any matrix
from water to blood are as follows. Reference cuvettes
are required for the measurements; experience shows
that these can be a source of inaccuracy, due to the
variable thickness of the layer, so that each cuvette
must be individually tested before use. Long periods
of measurement result in noticeable warming of the
sample, so that the depth and concentration of the
sample do not remain constant, leading to a signifi-
cant decrease of accuracy. Since the spectra them-
selves cannot be altered, the final result is at best an
approximation. ·, For example, allowance must be
made for the fact that the low water content of blood
(compared with physiological saline) cannot be sim-
ulated. Intensification, i.e. expansion of difference
spectra, is only an unsatisfactory provisional means
of dealing with this problem.
These described procedures have been applied to
EDTA-whole blood in vitro with encouraging results,
which justifies the expectation that the quantitative
100 200 300
Glucose (enzymatic) [mq/dl]
400
5 10 15
Glucose (enzymatic) [mmol/l]
20
Fig. 2. Correlation between glucose determination in whole
blood by IR-spectroscopy (ordinate) and enzymically
with glucose dehydrogenase (abscissa). N = 147,
y = 22.27 + 1.01 x, r = 0.863.
IR-spectroscopic determination of glucose will be
achieved, first in vitro, and later in vivo. Comparison
of glucose concentrations measured in this way with
those determined by the conventional glucose dehy-
drogenase method shows a correlation coefficient (r)
of 0.80 (fig. 2). For the measurement of relevant
hypoglycaemic glucose concentrations below 2.5
mmol/l, a further optimization of the specific signal
evaluation is necessary for a guarantee of satisfactor-
ily reproducible results.
2.4.1 Infrared spectroscopy with a CO2 laser
A convenional IR apparatus with a normal thermal
light source, even with the extra facilities described
above, is inadequate for the measurement of most
IR-active blood constituents. This is largely due to
the high background absorption resulting from the
water. Thermal emitters produce insufficiently pow-
erful absorption bands.
Principle
The development, in recent years, of laser techniques,
has enabled the quantitative determination of bio-
chemical substrates and metabolites, using high en-
ergy radiation sources. The combination of IR-spec-
troscopy with a CO2 laser has been considered for the
determination of glucose. Of the presently available
laser systems (e. g. Excimer, Ar+/Kr+, Nd/YAG and
CO2) only the CO2 laser provides IR-emission at 1000
nm, which is required for glucose measurement.
Evaluation
Compared with thermal light sources, lasers have the
advantage of greater coherence (optimal spatial and
temporal co-ordination), better collimation (lower di-
vergence) and higher spectral intensity (monochrom-
icity) (65). Introduction of this type of laser for the
spectroscopic determination will certainly enable a
precise measurement of glucose, even below 2.5
mmol/l, and provide a sound basis for the continuous
determination of the actual concentration of circulat-
ing blood glucose in vivo.
2.4.2 Infrared spectroscopy with ATR prisms
Kaiser (66) made the interesting suggestion of meas-
uring the physiological concentration of glucose in
very thin layers by using ATR (Attenuated Total
Reflection) prisms; this was intended to overcome the
problems of measurement in blood vessels or in well
vascularized tissues (ear lobes, lips, mucosa), without
the need to release blood.
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Principle
The phenomenon of total reflection is characterized
by the fact that reflected light energy at the boundary
layer of two media is capable of providing informa-
tion on the absorption of radiation by the optically
denser medium. Energy is not transferred from the
optically denser to the optically less dense medium.
The electromagnetic field, however, spreads outwards
in a narrow boundary layer to the optically denser
medium. If the less dense medium is not transparent,
the equilibrium between incident and reflected light
is disturbed by radiation absorption in the boundary
layer. This attenuated total reflection can be exploited
for spectrosocopic purposes.
Evaluation
The potential of this method was first assessed in the
studies of Kaiser (66 — 68). Replacement of transmis-
sion measurement by an ATR prism has the advan-
tages of the absence of dependence on the cuvette
light path, the extremely small accompanying tem-
perature difference, and the increase of sensitivity (69)
resulting from multiple reflection and the associated
large volume of analysed material.
2.5 Raman spectroscopy
Principle
Raman spectroscopy measures both the normal ab-
sorption and the scatter of incident monochromatic
light. In addition to the intense line of the excitation
frequency, there are additional, very weak Raman
lines with shifted frequencies. These represent oscil-
lation and rotation frequencies of molecules as they
absorb or release energy. During the measurement of
the absorption of incident radiation, these resonance
attenuations or intensifications lead to shifts of spon-
taneous fluorescence, which provide information
about changes in the energetic state, and moreover
the quantity of the molecules under investigation
(70-71).
Evaluation
The useful Raman spectra of glucose lie in the range
500 — 1000 cm"1. So far, however, satisfactory results
have only been obtained for aqueous solutions, due
to the fact that whole blood contains many other
chromophoric substances absorbing in this region.
These other blood constituents are responsible for an
intense background fluorescence, which renders im-
possible the identification of specific resonance-inten-
sified bands. It has not yet been possible to obtain
satisfactory results, even with laser sources. Moreover,
the accompanying technology is expensive. Electronic
background subtraction may subsequently improve
the usefulness of the technique for quantitative pur-
pose, but at the moment the desirable is separated
from reality by a Utopian divide (72).
Conclusions
For the observation and measurement of the dynamic
state of metabolic processes, it is necessary to move
away from traditional, in vitro investigations of single
parameters in random samples of body fluids (usually
blood) in favour of continuous and, as far as possible,
non-invasive methods. Invasive methods (biosensors)
have so far failed to perform adequately, and they
have the additional drawback of damage to the skin
and tissues, with the attendant consequences (infec-
tion, thrombosis, granuloma). The practical potential
of non-invasive spectroscopic methods is evident from
a certain level of success in their experimental appli-
cation, but their clinical application will depend on
further progress at the research front. In particular,
infrared spectroscopy linked to new techniques (laser
sources, reflection measurement, Fourier transforma-
tiorij computer back-up) offers the greatest hope for
further progress.
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